不妊治療薬の世界市場レポート 2025年

不妊治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9％で43億9,000万米ドルに成長します。予測期間の成長は、高齢化、ライフスタイル要因、生殖補助医療技術（アート）、個別化医療に起因しています。予測期間の主な動向としては、生殖補助医療（ART）、排卵誘発薬、ホルモン療法の進歩が挙げられます。

不妊治療薬市場は、世界の不妊率の上昇により成長を遂げています。不妊症とは、12ヶ月間妊娠を試みても妊娠できない状態を指します。不妊治療薬は、男女ともに不妊の問題に対処するために一般的に使用されています。不妊症の増加は、生理学的、ホルモン学的問題、ライフスタイルや環境的要因によるものです。女性の場合、不妊治療薬は排卵周期を調整するために使用されることが多く、これはこれらの医薬品の売上に直接影響します。例えば、2024年2月の国家統計局の報告によると、英国の合計特殊出生率（TFR）は、2021年の1.55から2022年には1.49に低下しました。その結果、世界中で不妊症の有病率が高まっていることが不妊治療薬の需要を促進し、不妊治療薬市場の成長に寄与しています。

不妊治療薬市場の成長は、男女の不妊症に大きく関連する肥満の蔓延によってさらに促進されると予想されます。この動向は、専門的治療の必要性、認知度の向上、政府の支援政策、肥満に関連する不妊の課題への対処を目指した継続的な調査努力に起因します。2023年3月に世界心臓連盟が発表したデータによると、肥満や過体重の影響を受けている人は、大人も子供も含めて世界全体で23億人という驚異的な数字となっています。動向は増加傾向を示しており、2025年には27億人まで増加すると予測されています。このように、肥満の急増は不妊治療薬市場の成長を推進する原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界不妊治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の不妊治療薬市場：成長率分析
• 世界の不妊治療薬市場の実績：規模と成長, 2019-2024
• 世界の不妊治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界不妊治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の不妊治療薬市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方箋不妊治療薬
• 市販薬不妊治療薬
• 世界の不妊治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• 皮下
• 筋肉内
• 世界の不妊治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の不妊治療薬市場処方不妊治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゴナドトロピン
• クロミフェンクエン酸塩
• レトロゾール
• GnRHアゴニスト
• GnRH拮抗薬
• プロゲステロン
• 世界の不妊治療薬市場市販の不妊治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 排卵予測キット
• 不妊治療サプリメント
• 妊娠検査モニター

第7章 地域別・国別分析

• 世界の不妊治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の不妊治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 不妊治療薬市場：競合情勢
• 不妊治療薬市場：企業プロファイル
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Berlex Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Janssen Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Novartis AG
• Procter & Gamble Health Limited
• Zydus Lifesciences Limited
• Livzon Pharmaceutical Group Inc.
• Abbott Laboratories
• Sanofi S.A.
• Eli Lilly and Company
• Serono Inc.
• Novagen Healthcare Pvt. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• AstraZeneca plc
• Aurobindo Pharma Ltd.
• Schering-Plough Corporation
• Regeneron Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 不妊治療薬市場2029：新たな機会を提供する国
• 不妊治療薬市場2029：新たな機会を提供するセグメント
• 不妊治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Fertility drugs encompass medications designed to stimulate the body's hormone release, regulating and prompting ovulation-the release of eggs from the ovaries.

These drugs fall into two main categories include prescription fertility drugs and over-the-counter variants. They are administered through various methods including oral ingestion, intravenous injection, subcutaneous injection (into the fatty tissue just below the skin), and intramuscular injection, catering to both male and female patients. Distribution channels for these drugs span hospital pharmacies, retail outlets, and online pharmacies, ensuring accessibility across different avenues for patients seeking fertility treatment.

The fertility drugs market research report is one of a series of new reports from The Business Research Company that provides fertility drugs market statistics, including fertility drugs industry global market size, regional shares, competitors with a fertility drugs market share, detailed fertility drugs market segments, market trends and opportunities, and any further data you may need to thrive in the fertility drugs industry. This fertility drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility drugs market size has grown strongly in recent years. It will grow from $3.13 billion in 2024 to $3.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing infertility rates, advances in reproductive medicine, assisted reproductive technologies (ART), and delayed childbearing.

The fertility drugs market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.9% . The growth in the forecast period can be attributed to the aging population, lifestyle factors, assisted reproductive technologies (art), and personalized medicine. Major trends in the forecast period include advancements in assisted reproductive technologies (ART), ovulation-inducing medications, and hormone therapy.

The market for fertility drugs is experiencing growth due to the rising rates of infertility worldwide. Infertility is defined as the inability to conceive after 12 consecutive months of trying. Fertility drugs are commonly used to address infertility issues in both men and women. The increasing incidence of infertility can be attributed to physiological and hormonal issues, as well as lifestyle and environmental factors. In women, fertility drugs are often employed to regulate ovulation cycles, which directly impacts the sales of these medications. For example, a report from the Office for National Statistics in February 2024 indicated that the total fertility rate (TFR) in the UK fell to 1.49 children per woman in 2022, down from 1.55 in 2021. Consequently, the growing prevalence of infertility around the world is driving demand for fertility drugs, thereby contributing to the growth of the fertility drug market.

Anticipated growth in the fertility drugs market is further propelled by the mounting prevalence of obesity, a condition significantly associated with infertility in men and women. This trend stems from the imperative for specialized treatments, augmented awareness, supportive governmental policies, and ongoing research endeavors aimed at addressing fertility challenges linked to obesity. Data from the World Heart Federation in March 2023 reveals a staggering 2.3 billion individuals, both adults and children, affected by obesity or overweight conditions globally. Projections indicate an upward trend, with estimates foreseeing a rise to 2.7 billion by 2025. Thus, the burgeoning prevalence of obesity serves as a driving force propelling growth within the fertility drugs market.

Leading companies in the fertility drugs market are concentrating on creating innovative solutions, such as peptide-based injectable treatments, to improve reproductive health outcomes. Peptide-based injectable treatments involve medications that use synthetic or naturally occurring peptides to stimulate or regulate hormonal activity, particularly concerning fertility and reproductive health. For example, in February 2024, Lupin Limited, a pharmaceutical company based in India, introduced a ganirelix acetate injection in the United States. This medication is frequently used in assisted reproductive technology (ART) protocols to prevent premature ovulation during controlled ovarian stimulation for women undergoing in vitro fertilization (IVF). As a GnRH antagonist, ganirelix acetate helps regulate hormone levels, allowing for better management of the ovarian stimulation process. The launch in the U.S. underscores Lupin's commitment to expanding its product range in the reproductive health sector and addressing the needs of patients undergoing fertility treatments.

Major players in the fertility drugs market are launching comprehensive campaigns centered around fertility care, aiming to secure competitive advantages. These campaigns, designed to raise awareness and educate the public on fertility-related issues, treatments, and reproductive health, play a crucial role in safeguarding access to fertility care. Pinnacle Fertility's August 2022 initiative, the Save IVF campaign in the US, is a prime example. Focused on potential legislation affecting family-building treatments like IVF in the absence of federal protection, this campaign advocates for preserving fertility care access. By mobilizing communities and encouraging individuals to support the cause through the #SaveIVF Pledge, Pinnacle Fertility seeks to protect fertility treatments' accessibility and combat legislative threats.

In March 2023, Sumitovant Biopharma Ltd., a US-based biopharmaceutical company, finalized the acquisition of Myovant Sciences Ltd. for an undisclosed sum. This strategic acquisition amplifies Sumitovant's collaborative capabilities, resources, and expertise, enabling them to effectively tackle unmet needs in women's health and prostate cancer. The combined entity aims to advance their joint pipeline's development, extending the reach of their distinct therapies to benefit diverse patient communities. Myovant Sciences Ltd., a US-based biotechnology firm, specializes in developing and commercializing novel treatments for women's diseases and endocrine disorders. Their focus areas include addressing conditions like heavy menstrual bleeding associated with uterine fibroids and female infertility. This acquisition marks a pivotal step for both companies in bolstering their offerings and impact within these critical medical domains.

Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma

North America was the largest region in the fertility drugs market in 2024. The Middle East is expected to be the fastest-growing region in the drugs for infertility market during the forecast period. The regions covered in the fertility drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The fertility drugs market consists of sales of clomiphene citrate, gonadotropins, and metformin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fertility Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fertility drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fertility drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fertility drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Drug: Prescription Fertility Drugs; Over-The-Counter Fertility drugs
• 2) By Route of Administration: Oral; Intravenous; Subcutaneous; Intramuscular
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Prescription Fertility Drugs: Gonadotropins; Clomiphene Citrate; Letrozole; GnRH Agonists; GnRH Antagonists; Progesterone
• 2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits; Fertility Supplements; Fertility Monitors
• Companies Mentioned: Merck & Co.; Ferring Pharmaceuticals Inc.; Bayer AG; Berlex Laboratories Inc.; Janssen Pharmaceutical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fertility Drugs Market Characteristics

3. Fertility Drugs Market Trends And Strategies

4. Fertility Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fertility Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Fertility Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Fertility Drugs Market Growth Rate Analysis
• 5.4. Global Fertility Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Fertility Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Fertility Drugs Total Addressable Market (TAM)

6. Fertility Drugs Market Segmentation

• 6.1. Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Fertility Drugs
• Over-The-Counter Fertility Drugs
• 6.2. Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• 6.3. Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Fertility Drugs Market, Sub-Segmentation Of Prescription Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gonadotropins
• Clomiphene Citrate
• Letrozole
• GnRH Agonists
• GnRH Antagonists
• Progesterone
• 6.5. Global Fertility Drugs Market, Sub-Segmentation Of Over-The-Counter Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ovulation Predictor Kits
• Fertility Supplements
• Fertility Monitors

7. Fertility Drugs Market Regional And Country Analysis

• 7.1. Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fertility Drugs Market

• 8.1. Asia-Pacific Fertility Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fertility Drugs Market

• 9.1. China Fertility Drugs Market Overview
• 9.2. China Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fertility Drugs Market

• 10.1. India Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fertility Drugs Market

• 11.1. Japan Fertility Drugs Market Overview
• 11.2. Japan Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fertility Drugs Market

• 12.1. Australia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fertility Drugs Market

• 13.1. Indonesia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fertility Drugs Market

• 14.1. South Korea Fertility Drugs Market Overview
• 14.2. South Korea Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fertility Drugs Market

• 15.1. Western Europe Fertility Drugs Market Overview
• 15.2. Western Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fertility Drugs Market

• 16.1. UK Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fertility Drugs Market

• 17.1. Germany Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fertility Drugs Market

• 18.1. France Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fertility Drugs Market

• 19.1. Italy Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fertility Drugs Market

• 20.1. Spain Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fertility Drugs Market

• 21.1. Eastern Europe Fertility Drugs Market Overview
• 21.2. Eastern Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fertility Drugs Market

• 22.1. Russia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fertility Drugs Market

• 23.1. North America Fertility Drugs Market Overview
• 23.2. North America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fertility Drugs Market

• 24.1. USA Fertility Drugs Market Overview
• 24.2. USA Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fertility Drugs Market

• 25.1. Canada Fertility Drugs Market Overview
• 25.2. Canada Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fertility Drugs Market

• 26.1. South America Fertility Drugs Market Overview
• 26.2. South America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fertility Drugs Market

• 27.1. Brazil Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fertility Drugs Market

• 28.1. Middle East Fertility Drugs Market Overview
• 28.2. Middle East Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fertility Drugs Market

• 29.1. Africa Fertility Drugs Market Overview
• 29.2. Africa Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fertility Drugs Market Competitive Landscape And Company Profiles

• 30.1. Fertility Drugs Market Competitive Landscape
• 30.2. Fertility Drugs Market Company Profiles
  • 30.2.1. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Berlex Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Janssen Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Fertility Drugs Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Novartis AG
• 31.3. Procter & Gamble Health Limited
• 31.4. Zydus Lifesciences Limited
• 31.5. Livzon Pharmaceutical Group Inc.
• 31.6. Abbott Laboratories
• 31.7. Sanofi S.A.
• 31.8. Eli Lilly and Company
• 31.9. Serono Inc.
• 31.10. Novagen Healthcare Pvt. Ltd.
• 31.11. Takeda Pharmaceutical Co. Ltd.
• 31.12. AstraZeneca plc
• 31.13. Aurobindo Pharma Ltd.
• 31.14. Schering-Plough Corporation
• 31.15. Regeneron Pharmaceuticals Inc.

32. Global Fertility Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fertility Drugs Market

34. Recent Developments In The Fertility Drugs Market

35. Fertility Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Fertility Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Fertility Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Fertility Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer